Molly White
Corporate Officer/Principal bei DYNE THERAPEUTICS, INC.
Profil
Molly White is currently the Vice President-Strategic Initiatives at Dyne Therapeutics, Inc. She previously served as the Chief Executive Officer at Myotonic Dystrophy Foundation from 2012 to 2019.
Ms. White holds a graduate degree from the University of Iowa and an undergraduate degree from The University of Montana.
Aktive Positionen von Molly White
Unternehmen | Position | Beginn |
---|---|---|
DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2020 |
Ehemalige bekannte Positionen von Molly White
Unternehmen | Position | Ende |
---|---|---|
Myotonic Dystrophy Foundation
Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Geschäftsführer | 01.12.2019 |
Ausbildung von Molly White
University of Iowa | Graduate Degree |
The University of Montana | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DYNE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Myotonic Dystrophy Foundation
Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Miscellaneous |